Clinical Trial Update: Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents [Phase 1]

View source ↗

Summary

Phase 1 clinical trial in adolescents evaluating physiologic response to bariatric surgery with adjunct semaglutide for obesity; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Obesity, Adolescent Obesity | Phase 1 | Status: RECRUITING